Home › Cardiac Sudden Death › NCT05135403

ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adult patient prescribed the ASSURE wearable cardioverter defibrillator
* Provided written informed consent to participate in the ASSURE Patient Registry

Exclusion Criteria:

* Patients who do not meet the Inclusion criteria

About the study

Active surveillance study using real-world data collected in the ASSURE Patient Registry. Outcome measures are based on analysis of ASSURE Registry data including data recorded by the WCD then annotated by clinical experts in electrophysiology.

What is being tested

• Defibrillation (device)

Sponsor: Kestra Medical Technologies, Inc. · Participants: 5,179 · Started: Nov 20, 2021

Contact the study team

• Kristin Eis, BSChE, MBA · Phone: 14256547596

Official record on ClinicalTrials.gov — NCT05135403

Locations in the U.S.

Conditions

• Cardiac Sudden Death

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.